Μake us preferred on Google Prime Minister Kyriakos Mitsotakis toured the newly established Athens LifeTech Park in Spata, a biotechnology facility he described as offering “a glimpse of the future.” Addressing attendees, he highlighted the sector’s growing momentum, noting that cumulative investment in Greece‘s domestic pharmaceutical industry has now surpassed 1 billion euros— positioning the country as a key player in Europe’s drive toward strategic autonomy in drug production.
Mitsotakis argued that the new park’s significance extends well beyond its role as a hub for preclinical research and start-up incubation. He framed it as a vital bridge to the Greek scientific diaspora, pointing to the country’s substantial presence in the life sciences abroad, particularly in the United States.
Building a robust innovation ecosystem at home, he said, has long been a government priority — one aimed at giving expatriate researchers a reason and a route to bring their expertise back to Greece.
The prime minister said the initiative was designed to create high-quality professional opportunities that would let young scientists build careers in their own country rather than seek them elsewhere. He expressed satisfaction at seeing that vision take concrete shape, stressing that the government’s broader aim is to link national economic growth directly to individual prosperity. Chief among his stated priorities, he added, remains the creation of well-paid jobs that allow young professionals to advance their careers without leaving Greece.
